Amneal Intermediate Inc
NASDAQ:AMRX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.36
8.83
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
AMRX Price Targets Summary
Amneal Intermediate Inc
According to Wall Street analysts, the average 1-year price target for AMRX is 9.86 USD with a low forecast of 9.09 USD and a high forecast of 10.5 USD.
AMRX Last Price Targets
Amneal Intermediate Inc
The latest public price target was made on Oct 2, 2024 by
Les Sulewski
from
Truist Financial
,
who expects
AMRX
stock to
rise by 42%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Les Sulewski
Truist Financial
|
12
USD
Upside 42% |
2 weeks ago
Oct 2, 2024
|
Amneal Pharmaceuticals price target raised to $12 from $10 at Truist
TheFly
|
|
Les Sulewski
Truist Financial
|
10
USD
Upside 18% |
2 weeks ago
Oct 1, 2024
|
Truist Securities Reiterates Buy Rating on Amneal Pharmaceuticals (AMRX)
StreetInsider
|
|
Les Sulewski
Truist Financial
|
9
USD
Upside 6% |
5 months ago
May 3, 2024
|
Amneal Pharmaceuticals (AMRX) PT Raised to $9 at Truist Securities
StreetInsider
|
David Amsellem
Piper Sandler
|
8
USD
Downside 5% |
6 months ago
Mar 21, 2024
|
Amneal Pharmaceuticals (AMRX) PT Raised to $8 at Piper Sandler
StreetInsider
|
Operating Income
Forecast
Operating Income Estimate
Amneal Intermediate Inc
For the last 8 years the compound annual growth rate for Amneal Intermediate Inc's operating income is 15%. The projected CAGR for the next 3 years is 29%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AMRX's stock price target?
Price Target
9.86
USD
According to Wall Street analysts, the average 1-year price target for AMRX is 9.86 USD with a low forecast of 9.09 USD and a high forecast of 10.5 USD.
What is Amneal Intermediate Inc's Revenue forecast?
Projected CAGR
8%
For the last 8 years the compound annual growth rate for Amneal Intermediate Inc's revenue is 14%. The projected CAGR for the next 3 years is 8%.
What is Amneal Intermediate Inc's Operating Income forecast?
Projected CAGR
29%
For the last 8 years the compound annual growth rate for Amneal Intermediate Inc's operating income is 15%. The projected CAGR for the next 3 years is 29%.
You don't have any saved screeners yet
